Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Achievement and Maintenance of Remission with Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis in Italy: 1-Year Data from UPHOLD, a Prospective Real-World Observational Study

Saved in:
Bibliographic Details
Published in:Rheumatology and Therapy
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867301675981602820
collection WordPress RSS
FRELIP Feed Integration
container_title Rheumatology and Therapy
description
discipline_display Rheumatology
discipline_facet Rheumatology
format Online Article
RSS Article
genre Journal Article
id rss_article:58299
institution FRELIP
journal_source_facet Rheumatology and Therapy
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Achievement and Maintenance of Remission with Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis in Italy: 1-Year Data from UPHOLD, a Prospective Real-World Observational Study
Rheumatology
General
Rheumatology
sub_discipline_display General
sub_discipline_facet General
subject_display Rheumatology
General
Rheumatology
Rheumatology
General
Rheumatology
subject_facet Rheumatology
General
Rheumatology
title Achievement and Maintenance of Remission with Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis in Italy: 1-Year Data from UPHOLD, a Prospective Real-World Observational Study
title_auth Achievement and Maintenance of Remission with Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis in Italy: 1-Year Data from UPHOLD, a Prospective Real-World Observational Study
title_full Achievement and Maintenance of Remission with Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis in Italy: 1-Year Data from UPHOLD, a Prospective Real-World Observational Study
title_fullStr Achievement and Maintenance of Remission with Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis in Italy: 1-Year Data from UPHOLD, a Prospective Real-World Observational Study
title_full_unstemmed Achievement and Maintenance of Remission with Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis in Italy: 1-Year Data from UPHOLD, a Prospective Real-World Observational Study
title_short Achievement and Maintenance of Remission with Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis in Italy: 1-Year Data from UPHOLD, a Prospective Real-World Observational Study
title_sort achievement and maintenance of remission with upadacitinib in patients with moderate-to-severe rheumatoid arthritis in italy: 1-year data from uphold, a prospective real-world observational study
topic Rheumatology
General
Rheumatology
url https://link.springer.com/article/10.1007/s40744-026-00845-2